Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9741 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.9138 |
High Similarity |
NPD5536 |
Phase 2 |
0.8783 |
High Similarity |
NPD228 |
Approved |
0.8475 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8359 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8346 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8136 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8136 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7966 |
Intermediate Similarity |
NPD1358 |
Approved |
0.792 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7891 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7788 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7761 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7761 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7761 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7744 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7731 |
Intermediate Similarity |
NPD3134 |
Approved |
0.773 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7681 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7652 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7652 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.763 |
Intermediate Similarity |
NPD1613 |
Approved |
0.763 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7615 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7537 |
Intermediate Similarity |
NPD7095 |
Approved |
0.75 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7482 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7478 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7478 |
Intermediate Similarity |
NPD2933 |
Approved |
0.746 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7438 |
Intermediate Similarity |
NPD968 |
Approved |
0.7424 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7414 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7414 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7385 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7385 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7373 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7364 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1511 |
Approved |
0.736 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7343 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7319 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7313 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7302 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.726 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7258 |
Intermediate Similarity |
NPD5451 |
Approved |
0.725 |
Intermediate Similarity |
NPD291 |
Approved |
0.7236 |
Intermediate Similarity |
NPD290 |
Approved |
0.7231 |
Intermediate Similarity |
NPD5691 |
Approved |
0.723 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD824 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7194 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7181 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7174 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7174 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7164 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7164 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD943 |
Approved |
0.7122 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6895 |
Approved |
0.709 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.708 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7075 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7068 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7068 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7063 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD2798 |
Approved |
0.705 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD2423 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7045 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7039 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7023 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7023 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7015 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7015 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD5297 |
Approved |
0.7 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7472 |
Approved |
0.6993 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6991 |
Remote Similarity |
NPD111 |
Approved |
0.6987 |
Remote Similarity |
NPD2821 |
Approved |
0.6986 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6985 |
Remote Similarity |
NPD2797 |
Approved |
0.6985 |
Remote Similarity |
NPD3053 |
Approved |
0.6985 |
Remote Similarity |
NPD1203 |
Approved |
0.6985 |
Remote Similarity |
NPD3055 |
Approved |
0.6978 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD3268 |
Approved |
0.6968 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6966 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD1669 |
Approved |
0.6962 |
Remote Similarity |
NPD2898 |
Approved |
0.6954 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6953 |
Remote Similarity |
NPD821 |
Approved |
0.6953 |
Remote Similarity |
NPD9379 |
Approved |
0.6953 |
Remote Similarity |
NPD9377 |
Approved |
0.695 |
Remote Similarity |
NPD3657 |
Discovery |
0.6944 |
Remote Similarity |
NPD2344 |
Approved |
0.6943 |
Remote Similarity |
NPD6232 |
Discontinued |
0.694 |
Remote Similarity |
NPD1281 |
Approved |
0.694 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6935 |
Remote Similarity |
NPD9697 |
Approved |
0.6934 |
Remote Similarity |
NPD4624 |
Approved |
0.6929 |
Remote Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD709 |
Approved |
0.6918 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6917 |
Remote Similarity |
NPD1778 |
Approved |
0.6914 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6912 |
Remote Similarity |
NPD5311 |
Approved |
0.6912 |
Remote Similarity |
NPD5310 |
Approved |
0.6912 |
Remote Similarity |
NPD3225 |
Approved |
0.6908 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD6386 |
Approved |
0.6908 |
Remote Similarity |
NPD6385 |
Approved |
0.6901 |
Remote Similarity |
NPD6653 |
Approved |
0.6901 |
Remote Similarity |
NPD2653 |
Approved |
0.6897 |
Remote Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD9295 |
Approved |
0.6894 |
Remote Similarity |
NPD9545 |
Approved |
0.6894 |
Remote Similarity |
NPD1182 |
Approved |
0.6892 |
Remote Similarity |
NPD6799 |
Approved |
0.6891 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD1608 |
Approved |
0.6889 |
Remote Similarity |
NPD2337 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6889 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6887 |
Remote Similarity |
NPD3111 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD4140 |
Approved |
0.6879 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6032 |
Approved |
0.6875 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD2354 |
Approved |
0.6863 |
Remote Similarity |
NPD37 |
Approved |
0.6857 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6853
|
Remote Similarity |
NPD4536 |
Approved |